CBX7 is a Polycomb group protein component of PRC1-like complexes that primarily functions as a transcriptional repressor through chr22 remodeling and histone modification 1. It mediates monoubiquitination of histone H2A and promotes H3K9me3, maintaining heterochromatin and gene repression [UniProt]. Beyond its canonical repressive role, CBX7 exhibits context-dependent functions: it represses cardiomyocyte proliferation postnatally via the TARDBP/RBM38 axis, and genetic Cbx7 deletion promotes cardiac regeneration in both neonatal and adult injury models 1. CBX7 negatively regulates adipogenesis, with Cbx7-null mice showing increased adiposity and enhanced adipocyte differentiation 2. In pathological settings, CBX7 acts as a tumor suppressor; its expression decreases in multiple carcinomas and inversely correlates with cancer progression 3. Notably, CBX7 is downregulated via DNMT1-mediated methylation in pancreatic ductal adenocarcinoma, promoting ERK phosphorylation and tumorigenesis 4. Surprisingly, CBX7 also functions as a methylation-dependent transcriptional activator in lymphoid cells, inducing cytokine production and ERK1/2 signaling essential for allergic responses 5. In cerebral cavernous malformations, CBX7 is pathologically upregulated downstream of KLF2 signaling 6. These findings reveal CBX7 as a multifunctional regulator with tissue- and context-specific roles in development, regeneration, and disease.